Will Stone
Will Stone is a former reporter at KUNR Public Radio.
-
COVID-19 has plateaued in the U.S., but hospitalizations of young adults are up about 40% since early March. And polls suggest some young adults may not be interested in getting vaccinated.
-
For a year, researchers have been studying and arguing over vitamin D's potential for helping protect against or treat COVID-19. The evidence is still not conclusive. -
Pausing use of the Johnson and Johnson vaccine looks unlikely to cause major problems in the overall U.S. vaccination effort, but some places counting on those doses are scrambling.
-
Get the first vaccine you're offered: that's the public health message. Each COVID-19 vaccine is highly effective at preventing severe disease, but some Americans want to choose the vaccine they get.
-
At least a dozen states have now seen an increase in COVID-19 hospitalizations. Epidemiologists explain what they think is behind the potential fourth surge of the pandemic in the U.S.
-
The possibility that vaccines meant to prevent the disease may also be a treatment for long COVID — when symptoms linger for months — has sparked optimism among patients and scientists.
-
An estimated 10% to 30% of people who get COVID-19 don't fully recover, but have chronic symptoms. Now some of these "long-haulers" are finding relief after getting the COVID-19 vaccine.
-
Researchers have quantified the price paid for fast-spreading COVID-19 infections. Patients who might have survived otherwise perished in crowded ICUs. -
The Aldaco family of Phoenix suffered more than most in this year of unfathomable losses. Three brothers perished in the pandemic: Jose in July, Heriberto in December and Gonzalo in February. -
As the new Johnson & Johnson COVID-19 vaccine rolls out, the health care community is trying to ward off misconceptions about it. The vaccine's one-shot feature may be what wins many over.
